alexa Comparative Analysis of Performance of PREVI Fluo TB Method by Using LED-Microscopy | Open Access Journals
ISSN: 2161-0703
Journal of Medical Microbiology & Diagnosis
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Comparative Analysis of Performance of PREVI Fluo TB Method by Using LED-Microscopy

Semaria Solomon1*, Solomon Gebreselassie2, Berhanu yitayew3 and Abebaw Kebede4

1St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia

2Department of Microbiology, Immunology, and Parasitology, Addis Ababa University, Ethiopia

3Institute of medicine and health sciences, college of medicine, Debre Brehan University, Ethiopia

4Ethiopian Public Health Institute, Addis Ababa, Ethiopia

*Corresponding Author:
Semaria Solomon
St. Paul’s Hospital Millennium Medical College
Addis Ababa, Ethiopia P. O. Box 25181
Tel: +251 911217830
E-mail: [email protected]

Received date: February 13, 2015; Accepted date: April 21, 2015; Published date: April 23, 2015

Citation: Solomon S, Gebreselassie S, Yitayew B, Kebede A (2015) Comparative Analysis of Performance of PREVI Fluo TB Method by Using LED-Microscopy. J Med Microb Diagn 4:184. doi:10.4172/2161-0703.1000184

Copyright: © 2015 Solomon S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Medical Microbiology & Diagnosis


There is a need for rapid, practical and accurate tuberculosis diagnostic tools that are adapted to resource-poor settings in order to ensure that those affected receive proper and timely treatment. Light-Emitting-Diode microscopy (LED) has recently been endorsed by the WHO for diagnosis of TB in these countries. A much recent smear diagnosis method, PREVI Fluo TB by using LED microscopy, has been made available. However, due to the novelty of the method, there is no information available on the specificity and sensitivity when compared to established methods such as the ordinary LED-Auramine O or the classical widely used Ziehl- Neelsen (ZN) in TB positive persons. This study was undertaken to compare the sensitivity, specificity, positive predictive value and negative predictive value of PREVI Fluo TB stain with ZN method and Auramine O-LED microscopy taking culture as reference. A prospective cross sectional study was conducted in St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia. Spot- Morning-Spot sputum samples from 248 TB suspected study participants were collected. The smear detection rate of PREVI Fluo TB, ZN, Auramine O and culture were found to be 35 (14.1%), 24(9.7%), 44(17.7%) and 30(12.1%) respectively. The sensitivity of the PREVI Fluo TB method was 76.67%, better than ZN and slightly less than Auramine O which were 59.07% and 78.13% respectively. Nevertheless, the specificity (94.5%) was lower than ZN (96.79%) and higher than Auramine O (91.2%). The negative likelihood ratio of PREVI Fluo TB, ZN, and Auramine O methods were 0.25, 0.45, and 0.24 respectively. The PREVI Fluo TB method had a PPV of 65.71% which is higher than the Auramine O (56.82%) but with a comparable NPV (96.71% and 96.57% respectively). The respective agreements of the ZN, Auramine O and PREVI Fluo TB methods with the gold standard were K=0.585, K=0.621 and K=0.664. There was a substantial agreement of PREVI Fluo TB result with ZN (k=0.636) and Auramine O methods (K=0.745).Given the practical benefits of PREVI Fluo TB for TB diagnosis, and comparable accuracy to the current standard of Auramine O fluorescence method and the gold standard culture, PREVI Fluo TB should be considered by TB diagnostic laboratories, as an alternative diagnostic tool for conventional Auramine O fluorescent stain.


Tuberculosis; ZN; Auramine O; PREVI Fluo TB


Tuberculosis (TB) is one of the oldest known human diseases and it is still one of the major causes of mortality and a major public health problem particularly in low-income countries. It is estimated that nearly one billion people will be infected with TB, 200 million develop the disease, and 35 million will die from TB during 2000- 2020 [1]. Different diagnostic methods are available for the diagnosis of

tuberculosis. The “gold standard” of TB diagnosis is identification of the bacilli after culturing it and growing sufficient quantities for analysis. However, culturing the TB bacteria is expensive and slow (taking weeks), and requires technical facilities that are often unavailable in developing countries. Thus, diagnosis is often based on a test for “acid-fast” bacteria in a sputum smear (made by smearing sputum on a microscope slide). In patients with active pulmonary TB, only an estimated 45% of infections are detected by sputum microscopy [2]. This test (Ziehl-Neelsen) has the advantage of being simple but is hampered by very low sensitivity; it may only detect half of all cases with active infection. It is also very dependent on the skill of the technician [3]. Specificity of ZN microscopy is high but sensitivity is variable (20-80%) and significantly reduced in extra-pulmonary TB and in HIV-infected TB patients [4]. Besides being labour-intensive, direct sputum smear microscopy may have considerable patient costs and inconvenience associated with the need to submit multiple sputum specimens over a period of up to three days [5].

A recently developed conventional fluorescent microscopy has documented higher sensitivity than ZN and takes less time, but uptake has been hampered by high cost due to expensive mercury vapour light sources, the need for regular microscopy maintenance, and the requirement for a dark room. Light emitting diode (LED) technology has been developed over recent years to allow the benefits of fluorescent microscopy without the associated costs [6]. Light emitting diode (LED) microscopy is a novel diagnostic tool developed primarily to allow resource-poor parts of the world access to the benefits of FM [7]. Compared to conventional mercury vapour fluorescence microscopes, LED microscopes are less expensive and have lower maintenance requirements. The diodes are very durable, do not require warm-up time, and do not contain toxic products [8]. Importantly, they are reported to perform equally well without a darkroom. These qualities make them attractive for use in low- and middle-income countries, and they have performed well in evaluations in these settings [9].

WHO recommend that conventional fluorescent microscopy must be replaced by LED microscopy and that LED microscopy be phased in as an alternative for conventional ZN light microscopy. Countries implementing LED microscopy should address laboratory staff training, country validation, introduction of appropriate quality assurance, and monitoring of impact on TB case detection and treatment outcome [6]. PREVI Fluo TB is the new and promising method for the diagnosis of PTB which is developed by Biomerieux SA. The method has similar principle with the conventional LED fluorescent microscope except that it has a fixative, decolorizer ethanol than the more toxic methanol and a red Thiazine Red counter staining dye. The fixative helps to fix the smear to the slide so that there would not be cross contamination and environmental contaminant. However, it needs to see its diagnostic efficacy with other commonly used diagnostic methods. Therefore, this study was designed to compare three methods of microscopy stains; the Ziehl-Neelsen, Auramine O and PREVI fluo TB taking culturing as a gold standard by using well characterized clinical specimens from patients who were assessed according to standard parameters for M. tuberculosis.


A hospital based comparative cross sectional study was conducted at St. Paul’s hospital Millennium Medical College, Addis Ababa, Ethiopia. All patients who were suspected for pulmonary tuberculosis during the data collection period were included. In this study 248 study participants were included. Three sputum samples were collected from each participants (spot-morning-spot). For every sample taken 3 smears were made for ZN, Auramine-O and PREVI Fluo TB stains. Hence, for every study participants a total of 9 slides were made, 3 for every sample. ZN smears were examined at 1,000× magnification, and fluorescent smears (in accordance with the International Union Against Tuberculosis and Lung Disease Working Group on Smear Microscopy) at 200×, with confirmation of positive smears at 400× magnification. Each of the microscopy readings were made without knowledge of the results of each slide and all microscopic readings were made without knowledge of the culture result. Smears were classified as positive when ≥1 AFB was detected per 100 fields, and patients were considered smear-positive if they had ≥1 positive smear [10]. The main outcomes for comparison were the sensitivity and specificity of PREVI Fluo compared with the sensitivity and specificity of ZN and Auramine O stains using LED microscope for the fluorescent stains and light microscopy for ZN. Culture was used as the reference standard. Sensitivity, specificity, positive and negative predictive values and likelihood ratios were calculated by using OpenEpi Version 2.3 for the PREVI Fluo LED, Auramine O LED and conventional ZN microscopy using mycobacterial culture as the reference standard. The agreement of PREVI Fluo TB method with the reference culture and its agreement with the ZN and Auramin O was calculated using Kappa statistics.


A total of 248 pulmonary tuberculosis suspected patients were included and from which 25.4% (63/248) had previous pulmonary tuberculosis history contact, while the remaining 74.6% had no history of previous pulmonary tuberculosis contact.

Laboratory investigation of every collected sputum samples of the study participants were done by the three methods and confirmed with the forth gold standard method TB culture. A total of 2,232 slides were made for ZN, Auramine O and PREVI Fluo methods, 744 for each type of method and 248 slides for each Spot-Morning-spot sample. By ZN method out of the total study participants 24(9.7%) were positive. In Auramine O 44(17.7%) were positive while in PREVI Fluo TB method, 35 (14.1%) participants were positive. From the sputum of the participants cultured on LJ culture media, 30(12.1%) of the participants became positive for TB bacilli whereas the remaining 213(85.9%) were negative (Table 1).

Methods PTBLab resultPositiveNegativeNo. (%)No. (%) TotalNo. (%)
ZN 24(9.7) 224(90.3) 248(100)
Auramine O 44(17.7)204(82.3) 248(100)
PREVI Fluo 35(14.1)213(85.9) 248(100)
Culture  30(12.1)218( 87.9) 248(100)

Table 1: Results of the ZN, Auramine O and PREVI Fluo TB methods in a comparative study of PREVI Fluo TB method among TB suspected patients.

Grading of bacilli (Scanty, 1+, 2+ and 3+) were also performed to see the differences among each method. For instance in the PREVI Fluo method, in ‘slide a (1st spot)’ 3 of the smears (1.2%) had a 1+ result, 3 (1.2%) had 2+, 10 (4%) had a 3+ and 10 (4%) had a scanty result. In ‘slide b (morning)’ 4 of the smears (1.6%) had a 1+ result, 4 (1.6%) had 2+, 10 (4%) had a 3+ and 10 (4%) had a scanty result. And at last, in ‘slide c (second spot) 6 of the smears (2.4%) had a 1+ result, 3 (1.2%) had 2+, 8 (3.2%) had a 3+ and 14 (5.6%) had a scanty result (a spot, b morning and c spot). The bacilli detected in culture from positive finding were graded as 23.3% (7/30), 10% (3/30), 33.3% (10/30) and 33.3% (10/30) for 1+, 2+, 3+ and scanty respectively (Table 2).

WHO grading scale ZNFreq (%) Auramine OFreq (%) PREVI FluoFreq (%)
Slide A(1st spot)Scanty 3(1.2) 14(46.7) 10(4)
1+ 8(3.2) 4(13.3) 3(1.2)
2+ 2(0.8) 4(13.3) 3(1.2)
3+ 6(2.4) 8(26.7) 10(4)
Slide B(morning)Scanty 3(1.2) 12(4.8) 10(4)
1+ 6(2.4) 6(2.4) 4(1.6)
2+ 4(1.6) 4(1.6) 4(1.6)
3+ 4(1.6) 8(3.2) 10(4)
Slide C (2nd spot)Scanty 14(5.6) 12(4.8) 14(5.6)
1+ 4(1.6) 4(1.6) 6(2.4)
2+ 4(1.6) 6(2.4) 3(1.2)
3+ 8(3.2) 7(2.8) 8(3.2)

Table 2: Grading results of PTB positive results in ZN, Auramine O and PREVI Fluo TB methods based on WHO grading system, 2012.

In a cross tabulation made between PTB culture result and the different methods, of the total 24 Zn positive slides 17(70.8%) were positive with LJ TB culture while 7(29.2%) were negative with culture and 13(5.8%) of the total culture positives were negative with ZN. Among the total 34 Auramine O positive slides, 25(56.8%) were positive with culture, the rest 19(43.2%) were negative with culture and 5(2.5%) of the total culture positives gave negative results with Auramine O. Within the total 35 PREVI Fluo positive slides, 23(65.7%) were also positive with culture, 12(34.3%) were negative and 7(3.3%) of the culture positives, gave negative result with PREVI fluo method. Concerning the agreement of the three methods with the gold standard (LJ culture), ZN has a kappa agreement result of K= 0.585, for Auramine O K=0.621 and PREVI Fluo TB K=0.664 (Table 3).The PREVI Fluo TB method has an agreement with the kappa scale of 0.745 with the Auramine O method and K=0.636 with regards to its agreement with the ZN method (Table 3). PTB positive results with the different stains related to HIV positive study participants is shown in the Table 4. Four (9.3%) of the total 43 HIV positives, were also positive for ZN smear, six (14%) were positive with Auramine O and 5 (11.6%) were positive with PREVI Fluo TB.

Variables Culture confirmed TB result
Yes (%)No (%)
Agreement with Kappa
ZN TB result
Positive 17(70.8) 7(29.2) 0.585
 Negative 13(5.8)  211(94.2)
Auramine O TB result
Positive 25(56.8) 19(43.2) 0.621
Negative 5(2.5) 199(97.5)
PREVI Fluo TB result
 Positive 23(65.7) 12(34.3) 0.664
 Negative  7(3.3) 206(96.7)

Table 3: PTB culture result related to ZN, Auramine O and PREVI Fluo for comparative analysis of PREVI Fluo among TB suspected patients.

PREVI Fluo TB result Auramine O PTB result Positive Negative
Yes (%)No (%)
Agreement with Kappa
PREVI Fluo TB result
Positive Count 31(88.6) 4(11.4) 0.745
Negative Count 13(6.1)  200(93.9)  
ZN PTB result
PREVI Fluo TB result
 Positive Count  20(57.1) 15(42.90   0.636
Negative Count 4(1.9) 209(98.1)

Table 4: Agreement of Kappa statistics of PREVI Fluo TB with Auramine O for comparative analysis of PREVI Fluo among TB suspected patients.

The sensitivity and Specificity of ZN, Auramine O and PREVI Fluo were 56.67% and 96.79%, 78.13 and 91.2% and 76.67% and 94.5% respectively. The different tests gave a PPV and NPV results of 70.83% and 94.2% (ZN), 56.82% and 96.57% (Auramine O) and 65.71% and 96.71% PREVI Fluo methods. In addition, the diagnostic accuracy for the different tests were 91.94, 89.52 and 92.34% respectively for ZN, Auramine O and PREVI Fluo TB. As well the likely hood ratio for a negative test was calculated to be 0.44, 0.23 and 0.24 for these tests (Table 5).

  ZN % (95%CI) Auramine O% (95%CI) PREVI Fluo% (95%CI)
Sensitivity 56.67(39.2-72.62) 78.13(61.24-88.98) 76.67(59.07-88.21)
Specificity 96.79(93.52-98.44) 91.28(6.67-94.3) 94.5(90.63-96.82)
Positive Predictive value 70.83(50.83-85.09) 56.82(42.22-70.32) 65.71(49.15-79.17)
Negative predictive value 94.2(90.33-96.58) 96.57(93.03-98.33) 96.71(993.37-98.4)
Diagnostic Accuracy 91.94(87.87-94.72) 89.52(85.08-0.92) 92.34(88.34-95.04)
Likely hood ratio of a Negative test 0.44 (0.38-0.52)  0.23(0.18-0.31) 0.24(0.19-0.33)

Table 5: The sensitivity, specificity, PPV, NPV, diagnostic accuracy and likely hood ratio, for the assessment for comparative analysis of PREVI Fluo.


The smear positivity rate of PTB by ZN, Auramine O and PREVI Fluo TB methods were investigated. In ZN method, out of the total study participants, 9.7%, in Auramine O 17.7% and in PREVI Fluo TB method 14.1% participants were positive for at least one slide. This has a similar finding from Vietnam where the prevalence of smearpositive TB by ZN method was 7% [11]. The sensitivity and specificity of ZN, PREVI Fluo and Auoramine O were 56.67% (39.2-72.62) and 96.79% (93.52-98.44), 76.67% (59.07-88.21) and 94.5% (90.63-96.82) and 78.13% (61.24-88.98) and 91.2% (86.67-94.3) respectively. ZN method was the least sensitive with highest specificity compared to the two methods. This is in line with Studies using Auramine O for comparison with conventional microscopy where sensitivity of conventional microscopy ranged from 0·48 to 0·93, and from 0·57 to 0·93 for fluorescence microscopy [12]. The decreased magnification used during LED microscopy, compared with light microscopy may also have contributed, particularly toward the sensitivity differences noted. This is similar to the study in Iran where the ZN sensitivity was found to be 51% lower than the sensitivity of Auramine O (57%) [13]. Again the finding of the current study is in agreement with the study conducted in Ethiopia, Kenya and Tanzania which used three spotmorning- spot sputum sample for the comparison of LED-FM and ZN with findings of 77% and 70.5% of sensitivity and 88% and 96.5% specificity respectively [14]. It is also in agreement with the study done in Turkey where the ZN sensitivity was much lower than the FM. The ZN sensitivity was found to be 67.6% and the FM was 85.2% [15]. Still Another study done in Lagos, Nigeria on the sensitivity of direct smear microscopy gave a sensitivity of 53.8% by the ZN method and gave a much lower sensitivity of ZN for HIV positive individuals [16].

Moreover, this study is in agreement with the study by Torrea et al, (2008) who reported FM detected on average 18% more positives than ZN. In addition, there was a substantial agreement with ZN TB smear positivity result and PREVI Fluo TB methods (K=0.636). Out of the total 35 PREVI Fluo positive cases, 20 (57.1%) had also a positive result with the Auramine O, while 14 had a discordant result. Out of 9.7% of the ZN total cases 1.9% were negative with PREVI Fluo.

The smear negativity rate of this study was seen in ZN stained slides from which 24(9.7%) were positive by ZN and 30(12.1%) were confirmed culture positive. Out of these 6 of the slides which were missed by ZN were positive by culture. Therefore the ZN miss diagnosed as a negative 2.4% of the confirmed positive cases. In a similar study in Vietnam the smear negativity was reported to be 2% [11]. For those patients with a high clinical suspicion, clinicians must face the dilemma of empirically treating or waiting for up to 8 weeks for the final culture results. These newer fluorescent diagnostic tests are most suitable in identifying these smear negative cases, as they did not miss any of these cases in this study.

The detection rate in ZN was also lower than the new PREVI Fluo methods with a smear detection rate of 9.7% and 14.1% respectively. The detection rate of bacilli by ZN method is lower in HIV positive individuals [17] similarly in the current study ZN is slightly lower than Auramine O and PREVI Fluo.

The sensitivity and specificity of ZN method were 56.7% and 96.8% respectively with culture taken as a gold standard and PPV, NPV and diagnostic accuracy were found to be 70.8%, 94.2% and 91.9% correspondingly. Sensitivity of ZN was lower than any other methods. This is in line with the report by Khatun et al., (2011) found that the sensitivity of and specificity of ZN were lower than LED microscope which were 56.06% and 97.61% respectively, also in a similar study in the Netherlands with regards to ZN, 61.1% and 98.9% sensitivity and specificity were found respectively [18]. The sensitivity of ZN in this study was lower than that found in Tanzania (61.8%) [19]. Reasons for this could be that the concentrated smear method was used for the study in Tanzania and all study participants were HIV positive. However, the finding is in contrast with the report by Maryline et al. (2011) who found a sensitivity of 72%, this might be due to whether the Ziehl Neelsen staining method is always done first, as might be required in a diagnostic setting. A factor that may contribute to variability in the findings between these studies is of study participant difference. Again in their study all the study participants were only HIV positives, but in the current study only 43 HIV positive individuals were included. Similar finding to this study was also reported from India which was 55.55% sensitivity of ZN and 71.85% sensitivity of Auramine O. Direct fluorescent microscopy detected 9.29% paucibacillary sputum samples that were missed on ZN staining [20].

The PPV and NPV of ZN gave a value of 70.8% and 94.2% respectively while the Auramine O gave 56.82% and 96.57%. This is in agreement with the report from Turkey where the NPV of ZN was lower than the fluorescent staining [15]. The test agreement of ZN with Culture gave a value of 0.585 Kappa which was lower than the Auoramine O and PREVI Fluo result. It had a moderate agreement with culture, however there was a substantial agreement of ZN with PREVI Fluo (kappa=0.636). Although there was substantial agreement between these two methods, still ZN had lower sensitivity.

The rate of false negativity in ZN was higher than PREVI Fluo and Auramine O which means the method had high probability to loss true positive cases. However, the false positivity of ZN was lower than the two methods this suggested that the probability of ZN to detect non bacilli artifacts was lower than the two methods. The likelihood ratio of ZN was slightly higher than PREVI Fluo and Auramine O methods which were 0.45, 0.25 and 0.24 respectively. Compare to these two methods ZN was not a good diagnostic method.

A total of 744 slides were run with Auramine O, spot-morning-spot samples were smeared and stained and from which 17.7% were positive from the total 248 patients. In a similar study in Kenya [21] overall 23% of FM smears were positive which was higher than the current study with Auramine O. This could be as result that they used higher sample size in their study (21,104 smears were included in the study). In another study, sensitivity and specificity documented for the different modalities were 84.7% and 98.9% [18], respectively, for the LED assessment with Auramine O. The increased sensitivity of Auramine O is greatest in low grade positives. The proportion of low grade positives in the population served may thus determine the relative sensitivity of the method over LM in any setting. This becomes more clear with the finding that the PPV for the Auramine O is 56.82% while for the ZN it is 70.83% (as the PPV gives lower result, it could be an indication that the test could be giving more false positives). One disadvantage of the fluorescent staining technique is that it may sometimes yield false positive results. However, most of these can be prevented by restaining the smear by the ZN method for bright-light microscopy [22].

Apart from these studies, in a study done in kenya, Nairobi, there was no difference in sensitivity and specificity between LED-FM and ZN microscopy [17]. This could be explained by the great experience of study technicians with the ZN method and the fact that they never used FM before. Also they did not process the culture reference standard for each participant used for microscopy as they were requesting a 4th sample for culture confirmation in which case not all patients were able to produce a 4th specimen for culture and among those who did; the macroscopic appearance of the 4th specimen was of poorer quality than those specimens submitted for microscopy. With regards to its agreement with the kappa scale in relation to the gold standard, culture, Auramine O in this study has a kappa of 0.621(substantial agreement) which agrees better than the ZN (0.585, moderate agreement) but still a little less than the PREVI Fluo method (0.664, substantial agreement). In addition the Auramine O and the PREVI Fluo had a substantial agreement of K=0.745. Auramine O had a smear positivity of 14% in HIV positive which was higher than the ZN (9.3%) but with no significant difference whereas in PREVI Fluo it had a case detection rate of 11.6%.

Concerning the sensitivity and specificity of Auramine O stain, it had a sensitivity of 78.13% and a specificity of 91.2%, which is significantly higher in sensitivity than ZN and lower than the ZN finding in specificity (56.7% and 96.79% respectively for ZN). This is in agreement with the study in Ethiopia, Nepal, Nigeria, and Yemen [14] using three LED-FM smears per patient resulted in sensitivity of 77.1% (73.3%–80.6%). The lower specificity may thus be the impact of the larger amount of operational data collected in this study, at the cost of a less-than-ideal reference standard.

In this study smears were made within a three-specimen set from the same patient and for processed by different techniques. This will ensure the issue of bias associated with which sputum sample is used for which slide, that is morning sputum sample being used for one method alone kind of bias is eliminated. The negative likelihood ratio of Auramine O was smaller than ZN and PREVI Fluo methods, which were 0.24, 0.45, and 0.25 respectively. Compared to these two methods Auramine O was a very good diagnostic method since its negative likelihood ratio was nearest to zero.

In the current study the smear detection rate of PREVI Fluo was found to be 14.1% while the culture confirmed cases were 12.1%.This is more close to culture results compared to the other two methods (ZN and Auramine O). There was a substantial agreement with PREVI Fluo TB result and TB Auramine O methods (K=0.745). Out of the total 34 PREVI Fluo positive cases, 88.6% had also a positive result with the Auramine O, while only 4 had a discordant result. Furthermore, while 6.1% of the Auramine O totals (17.7%) were negative with PREVI Fluo.

The sensitivity of the PREVI Fluo method was 76.67% better than ZN and slightly less than Auramine O which were 59.07% and 78.13% respectively. Nevertheless, the specificity (94.5%) was lower than ZN (96.79%) and higher than Auramine O (91.2%). The likely hood Ratio of a negative test of the PREVI Fluo method (0.24) was lower than ZN (0.44) which indicated PREVI Fluo is a better diagnostic test than ZN since its value is closer to zero.

The PREVI Fluo TB method has a PPV of 65.71% which is lower than the Auramine O (56.82%) but with a comparable NPV (96.71% and 96.57% respectively). Hence, in the case of any infectious disease with public health implications, it is important to have a test or rule that has a high sensitivity, negative predictive value and Positive predictive value, so that patients with true disease are treated and those with a low possibility of disease can be discharged from the hospital safely without treatment. The rate of false positivity is lower as well than the Auramine O method. In PREVI Fluo TB method the counter staining dye makes the back ground of the smear bright red color which creates a good contrast between the fluorescing bacilli and back ground. The back ground helps the stain to have fewer artifacts. Consequently, even if epithelial and other WBCs are present, the stain can use that as an advantage to give a better background contrast. Furthermore, it helps the technician better to focus and find the field making it easier to differentiate when the objective is out of focus. Subsequently, this could be ideal for the inexperienced technician.


The PREVI Fluo TB fluorescent staining method had nearly identical sensitivity compared to the conventional Auramine O fluorescent staining method for the detection of AFB in patient specimens. It had a significant higher sensitivity than ZN staining method, but the specificity was less than ZN. Auramine O also had significantly higher sensitivity than ZN whereas the specificity was lower.


The financial support obtained from the graduate program of Addis Ababa University, Biomerieux SA and EPHI is acknowledged.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11671
  • [From(publication date):
    June-2015 - Oct 22, 2017]
  • Breakdown by view type
  • HTML page views : 7908
  • PDF downloads :3763

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version